Diverse gene expression in human Regulatory T cell subsets uncovers connection between regulatory T cell genes and suppressive function

Journal of Immunology

Volumn 195, Issue 8, 2015, Pages 3642-3653

  Hua, Jing ^a   Davis, Scott P ^a   Hill, Jonathan A ^a   Yamagata, Tetsuya ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CELL INTERACTION; CELL SPECIFICITY; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EFFECTOR CELL; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REPRESSION; GENETIC CORRELATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VALIDATION PROCESS; FEMALE; GENE EXPRESSION REGULATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; PHYSIOLOGY;

FEMALE; GENE EXPRESSION REGULATION; HUMANS; LYMPHOCYTE ACTIVATION; MALE; T-LYMPHOCYTES, REGULATORY;

EID: 84943521862     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500349     Document Type: Article

References (56)

1. Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell 133:775-787.
2. Josefowicz S. Z., L. F. Lu, and A. Y. Rudensky. 2012. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30:531-564.
3. Buckner, J. H. 2010. Mechanisms of impaired regulation by CD4 (+) CD25 (+) FOXP3 (+) regulatory T cells in human autoimmune diseases. Nat. Rev. Immunol. 10:849-859.
4. Shevach, E. M. 2009. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30:636-645.
5. Ziegler, S. F. 2006. FOXP3: of mice and men. Annu. Rev. Immunol. 24:209-226.
6. Fontenot, J. D., M. A. Gavin, and A. Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4:330-336.
7. Hill, J. A., M. Feuerer, K. Tash, S. Haxhinasto, J. Perez, R. Melamed, D. Mathis, and C. Benoist. 2007. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 27:786-800.
8. Feuerer, M., J. A. Hill, D. Mathis, and C. Benoist. 2009. Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat. Immunol. 10:689-695.
9. Zheng, Y., A. Chaudhry, A. Kas, P. de Roos, J. M. Kim, T. T. Chu, L. Corcoran, P. Treuting, U. Klein, and A. Y. Rudensky. 2009. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T (H) 2 responses. Nature 458:351-356.
10. Chaudhry, A., D. Rudra, P. Treuting, R. M. Samstein, Y. Liang, A. Kas, and A. Y. Rudensky. 2009. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326:986-991.
11. Koch, M. A., G. Tucker-Heard, N. R. Perdue, J. R. Killebrew, K. B. Urdahl, and D. J. Campbell. 2009. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10:595-602.
12. Chung, Y., S. Tanaka, F. Chu, R. I. Nurieva, G. J. Martinez, S. Rawal, Y. H. Wang, H. Lim, J. M. Reynolds, X. H. Zhou, et al. 2011. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat. Med. 17:983-988.
13. Koch, M. A., K. R. Thomas, N. R. Perdue, K. S. Smigiel, S. Srivastava, and D. J. Campbell. 2012. T-bet (+) Treg cells undergo abortive Th1 cell differentiation due to impaired expression of IL-12 receptor b2. Immunity 37:501-510.
14. Baecher-Allan, C., E. Wolf, and D. A. Hafler. 2006. MHC class II expression identifies functionally distinct human regulatory T cells. J. Immunol. 176:4622-4631.
15. Ito, T., S. Hanabuchi, Y. H. Wang, W. R. Park, K. Arima, L. Bover, F. X. Qin, M. Gilliet, and Y. J. Liu. 2008. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 28:870-880.
16. Duhen, T., R. Duhen, A. Lanzavecchia, F. Sallusto, and D. J. Campbell. 2012. Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells. Blood 119:4430-4440.
17. Dong, S., S. Maiella, A. Xhaard, Y. Pang, L. Wenandy, J. Larghero, C. Becavin, A. Benecke, E. Bianchi, G. Socié, and L. Rogge. 2013. Multiparameter singlecell profiling of human CD4+FOXP3+ regulatory T-cell populations in homeostatic conditions and during graft-versus-host disease. Blood 122:1802-1812.
18. Sakaguchi, S., M. Miyara, C. M. Costantino, and D. A. Hafler. 2010. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 10:490-500.
19. Pfoertner, S., A. Jeron, M. Probst-Kepper, C. A. Guzman, W. Hansen, A. M. Westendorf, T. Toepfer, A. J. Schrader, A. Franzke, J. Buer, and R. Geffers. 2006. Signatures of human regulatory T cells: an encounter with old friends and new players. Genome Biol. 7:R54.
20. Ferraro, A., A. M. D'Alise, T. Raj, N. Asinovski, R. Phillips, A. Ergun, J. M. Replogle, A. Bernier, L. Laffel, B. E. Stranger, et al. 2014. Interindividual variation in human T regulatory cells. Proc. Natl. Acad. Sci. USA 111:E1111-E1120.
21. Grossman, W. J., J. W. Verbsky, W. Barchet, M. Colonna, J. P. Atkinson, and T. J. Ley. 2004. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21:589-601.
22. Wan, Q., L. Kozhaya, A. ElHed, R. Ramesh, T. J. Carlson, I. M. Djuretic, M. S. Sundrud, and D. Unutmaz. 2011. Cytokine signals through PI-3 kinase pathway modulate Th17 cytokine production by CCR6+ human memory T cells. J. Exp. Med. 208:1875-1887.
23. Wang, Y., M. A. Su, and Y. Y. Wan. 2011. An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 35:337-348.
24. Wohlfert, E. A., J. R. Grainger, N. Bouladoux, J. E. Konkel, G. Oldenhove, C. H. Ribeiro, J. A. Hall, R. Yagi, S. Naik, R. Bhairavabhotla, et al. 2011. GATA3 controls Foxp3. regulatory T cell fate during inflammation in mice. J. Clin. Invest. 121:4503-4515.
25. Fernandez, I., R. Zeiser, H. Karsunky, N. Kambham, A. Beilhack, K. Soderstrom, R. S. Negrin, and E. Engleman. 2007. CD101 surface expression discriminates potency among murine FoxP3+ regulatory T cells. J. Immunol. 179:2808-2814.
26. Nicholson, I. C., C. Mavrangelos, D. R. Bird, S. Bresatz-Atkins, N. G. Eastaff-Leung, R. H. Grose, B. Gundsambuu, D. Hill, D. J. Millard, T. J. Sadlon, et al. 2012. PI16 is expressed by a subset of human memory Treg with enhanced migration to CCL17 and CCL20. Cell. Immunol. 275:12-18.
27. Pollak, M. 2012. The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat. Rev. Cancer 12:159-169.
28. Álvarez-Errico, D., I. Oliver-Vila, E. Ainsua-Enrich, A. M. Gilfillan, C. Picado, J. Sayós, and M. Martín. 2011. CD84 negatively regulates IgE high-affinity receptor signaling in human mast cells. J. Immunol. 187:5577-5586.
29. Ihn, H. J., D. H. Kim, S. S. Oh, C. Moon, J. W. Chung, H. Song, and K. D. Kim. 2011. Identification of Acvr2a as a Th17 cell-specific gene induced during Th17 differentiation. Biosci. Biotechnol. Biochem. 75:2138-2141.
30. Sukiennicki, T. L., and D. J. Fowell. 2006. Distinct molecular program imposed on CD4+ T cell targets by CD4+CD25+ regulatory T cells. J. Immunol. 177:6952-6961.
31. Weber, C. E., N. Y. Li, P. Y. Wai, and P. C. Kuo. 2012. Epithelial-mesenchymal transition, TGF-β, and osteopontin in wound healing and tissue remodeling after injury. J. Burn Care Res. 33:311-318.
32. Li, M. O., Y. Y. Wan, and R. A. Flavell. 2007. T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26:579-591.
33. Munn, D. H., and A. L. Mellor. 2013. Indoleamine 2, 3 dioxygenase and metabolic control of immune responses. Trends Immunol. 34:137-143.
34. So, T., S. W. Lee, and M. Croft. 2008. Immune regulation and control of regulatory T cells by OX40 and 4-1BB. Cytokine Growth Factor Rev. 19:253-262.
35. Etzerodt, A., and S. K. Moestrup. 2013. CD163 and inflammation: biological, diagnostic, and therapeutic aspects. Antioxid. Redox Signal. 18:2352-2363.
36. Moseman, A. P., E. A. Moseman, S. Schworer, I. Smirnova, T. Volkova, U. von Andrian, and A. Poltorak. 2013. Mannose receptor 1 mediates cellular uptake and endosomal delivery of CpG-motif containing oligodeoxynucleotides. J. Immunol. 191:5615-5624.
37. Pagel, C. N., D. K. Wasgewatte Wijesinghe, N. Taghavi Esfandouni, and E. J. Mackie. 2014. Osteopontin, inflammation and myogenesis: influencing regeneration, fibrosis and size of skeletal muscle. J. Cell Commun. Signal. 8:95-103.
38. Burzyn, D., W. Kuswanto, D. Kolodin, J. L. Shadrach, M. Cerletti, Y. Jang, E. Sefik, T. G. Tan, A. J. Wagers, C. Benoist, and D. Mathis. 2013. A special population of regulatory T cells potentiates muscle repair. Cell 155:1282-1295.
39. Kranz, T. M., S. Ekawardhani, M. K. Lin, S. R. Witzmann, F. Streit, U. Schuelter, H. Bauer, D. Henseler, J. D. Turner, C. P. Muller, et al. 2012. The chromosome 15q14 locus for bipolar disorder and schizophrenia: is C15orf53 a major candidate gene? J. Psychiatr. Res. 46:1414-1420.
40. Feuerer, M., J. A. Hill, K. Kretschmer, H. von Boehmer, D. Mathis, and C. Benoist. 2010. Genomic definition of multiple ex vivo regulatory T cell subphenotypes. Proc. Natl. Acad. Sci. USA 107:5919-5924.
41. Mandapathil, M., M. Szczepanski, M. Harasymczuk, J. Ren, D. Cheng, E. K. Jackson, E. Gorelik, J. Johnson, S. Lang, and T. L. Whiteside. 2012. CD26 expression and adenosine deaminase activity in regulatory T cells (Treg) and CD4 (+) T effector cells in patients with head and neck squamous cell carcinoma. OncoImmunology 1:659-669.
42. Salgado, F. J., A. Pérez-Díaz, N. M. Villanueva, O. Lamas, P. Arias, and M. Nogueira. 2012. CD26: a negative selection marker for human Treg cells. Cytometry A 81:843-855.
43. Sojka, D. K., and D. J. Fowell. 2011. Regulatory T cells inhibit acute IFN-γ synthesis without blocking T-helper cell type 1 (Th1) differentiation via a compartmentalized requirement for IL-10. Proc. Natl. Acad. Sci. USA 108:18336-18341.
44. Rubtsov, Y. P., J. P. Rasmussen, E. Y. Chi, J. Fontenot, L. Castelli, X. Ye, P. Treuting, L. Siewe, A. Roers, W. R. Henderson, Jr., et al. 2008. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28:546-558.
45. Fuhrman, C. A., W. I. Yeh, H. R. Seay, P. Saikumar Lakshmi, G. Chopra, L. Zhang, D. J. Perry, S. A. McClymont, M. Yadav, M. C. Lopez, et al. 2015. Divergent phenotypes of human regulatory T cells expressing the receptors TIGIT and CD226. J. Immunol. 195:145-155.
46. Yan, Q., V. N. Malashkevich, A. Fedorov, E. Fedorov, E. Cao, J. W. Lary, J. L. Cole, S. G. Nathenson, and S. C. Almo. 2007. Structure of CD84 provides insight into SLAM family function. Proc. Natl. Acad. Sci. USA 104:10583-10588.
47. Arnaldez, F. I., and L. J. Helman. 2012. Targeting the insulin growth factor receptor 1. Hematol. Oncol. Clin. North Am. 26:527-542, vii-viii.
48. Ebert, L. M., P. Schaerli, and B. Moser. 2005. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. Mol. Immunol. 42:799-809.
49. Zanin-Zhorov, A., Y. Ding, S. Kumari, M. Attur, K. L. Hippen, M. Brown, B. R. Blazar, S. B. Abramson, J. J. Lafaille, and M. L. Dustin. 2010. Protein kinase C-theta mediates negative feedback on regulatory T cell function. Science 328:372-376.
50. Forward, N. A., S. J. Furlong, Y. Yang, T. J. Lin, and D. W. Hoskin. 2010. Signaling through TLR7 enhances the immunosuppressive activity of murine CD4+CD25+ T regulatory cells. J. Leukoc. Biol. 87:117-125.
51. van Loosdregt, J., Y. Vercoulen, T. Guichelaar, Y. Y. Gent, J. M. Beekman, O. van Beekum, A. B. Brenkman, D. J. Hijnen, T. Mutis, E. Kalkhoven, et al. 2010. Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization. Blood 115:965-974.
52. Tognon, C. E., and P. H. Sorensen. 2012. Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy. Expert Opin. Ther. Targets 16:33-48.
53. Sablina, A. A., M. Hector, N. Colpaert, and W. C. Hahn. 2010. Identification of PP2A complexes and pathways involved in cell transformation. Cancer Res. 70:10474-10484.
54. Brdicková, N., T. Brdicka, P. Angelisová, O. Horváth, J. Spicka, I. Hilgert, J. Paces, L. Simeoni, S. Kliche, C. Merten, et al. 2003. LIME: a new membrane Raft-associated adaptor protein involved in CD4 and CD8 coreceptor signaling. J. Exp. Med. 198:1453-1462.
55. Hur, E. M., M. Son, O. H. Lee, Y. B. Choi, C. Park, H. Lee, and Y. Yun. 2003. LIME, a novel transmembrane adaptor protein, associates with p56lck and mediates T cell activation. J. Exp. Med. 198:1463-1473.
56. von Boehmer, H., and C. Daniel. 2013. Therapeutic opportunities for manipulating T (Reg) cells in autoimmunity and cancer. Nat. Rev. Drug Discov. 12:51-63.